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To understand the interactions between innate and adaptive immunity, and specifically how
virally infected macrophages impact T cell function, novel assays examining the ability of
macrophages to present antigen to CD8+ T cells are needed. In the present study, we
have developed a robust in vitro assay to measure how antigen presentation by human
monocyte-derived macrophages (MDMs) affects the functional capacity of autologous
CD8+ T cells. The assay is based on the polyfunctional characteristics of antigen-specific
CD8+ T cells, and is thus called a Mac-CD8 Polyfunctionality Assay. Following purification
of monocytes and their maturation to MDMs, MDMs were pulsed with an antigenic pep-
tide to be presented to CD8+ T cells. Peptide-pulsed MDMs were then incubated with
antigen-specific CD8+ T cells in order to assess the efficacy of antigen presentation to T
cells. CD8+ T cell polyfunctionality was assessed by staining with mAbs to IFN-γ, TNF-α,
and CD107a in a multi-color intracellular cytokine staining assay. To highlight the utility of
the Mac-CD8 Polyfunctionality Assay, we assessed the effects of influenza infection on the
ability of human macrophages to present antigen to CD8+ T cells. We found that influenza
infection of human MDMs can alter the effector efficacy of MDMs to activate more CD8+
T cells with cytotoxic capacity. This has important implications for understanding how the
virus-infected macrophages affect adaptive immunity at the site of infection.
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INTRODUCTION
A robust CD8+ T cell response represents an essential component
of controlling viral infections of the respiratory tract, including
infection with influenza A virus (IAV). Each year seasonal out-
breaks of IAV cause approximately 500,000 deaths worldwide (1).
However, if a novel IAV strain enters a human population, and
there is no pre-existing immunity, a global pandemic can result.
Such pandemics can potentially cause millions of IAV-associated
fatalities, as was observed during the 1918–1919 Spanish influenza
virus pandemic (2). Unlike an antibody response, an effective
CD8+ T cell response can offer heterosubtypic immunity against
IAV, protecting individuals against both the current circulating
IAV strain and novel pandemic strains (3). Thus, developing tech-
niques to assess CD8+ T cell activation in humans, in particular
in the context of an IAV infection, represents an important com-
ponent of understanding the host anti-viral immune response.
Influenza A virus primarily infects and replicates within epithe-
lial cells of the respiratory tract. IAV can also infect dendritic cells
(DCs) and macrophages, although such infections are typically
considered to be abortive (4). IAV infection of human DCs affects
the subsequent induction of CD8+ T cell responses (5). Similarly,
IAV infection of macrophages may affect antigen presentation to
CD8+ T cells at the site of infection. The ability of macrophages
to present viral antigen to CD8+ T cells represents an essen-
tial component an effective anti-IAV immune response, as unlike
epithelial cells, macrophages are able to induce both CD8+ T cell
cytolysis and cytokine production (6). Consistent with a role for
macrophages in the CD8+ T cell response, impaired macrophage
function in mice is associated with a diminished CD8+ T cell
response and increased susceptibility to IAV infection (7). Due to
the longevity of macrophages (8), the ability of a viral infection to
alter macrophage-CD8+ T cells interactions may have long-term
consequences for the adaptive immune response of the host.
Currently, the majority of studies investigating macrophage-
CD8+ T cell interactions have focused on murine models of
infection (6, 7). This may reflect the fact that to the best of our
knowledge, no assay has been developed to assess the ability of
human macrophages to present antigen to CD8+ T cells. This is
despite the fact that such assays have been established to examine
human DC-CD8+ T cell interactions (5). Here, we present a simple
and robust in vitro assay to assess CD8+ T cell polyfunctional-
ity following antigen presentation by human monocyte-derived
macrophages (MDMs). To demonstrate the utility of this assay,
we used this method to assess the effects of IAV infection of
human MDMs on CD8+ T cell polyfunctionality. This assay can
be further utilized to understand the impact of specific viruses,
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The GFP-labeled influenza virus strain A/PR8-GFP/8/34 (GFP-
PR8/34; H1N1) (9) was used in all experiments. Virus stocks were
prepared in embryonated eggs and titers of infectious virus were
determined by three independent plaque assays on Madin-Darby
Canine Kidney (MDCK) cells (10).
ISOLATION OF HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS
Human peripheral blood mononuclear cells (PBMCs) were iso-
lated from blood obtained from anonymized buffy coats of healthy
donors who consented to the use of their blood for scientific
research (Sanquin, The Netherlands or Australian Red Cross, Aus-
tralia). Where relevant, experiments were approved by the Ethics
Committee of the University of Melbourne, Australia. PMBCs
were isolated from buffy coats by density gradient centrifuga-
tion using Lymphoprep (Axis-Shield, Norway). PBMCs were then
washed, resuspended in 10% DMSO (v/v) with heat-inactivated
FCS and frozen in liquid nitrogen. Alternatively, washed PBMCs
were used fresh and monocytes were isolated by adherence as
described below.
DIFFERENTIATION, INFECTION, AND ANALYSIS OF HUMANMDMs
Peripheral blood mononuclear cells were resuspended in RPMI-
1640 supplemented with 2% heat-inactivated human sera (Sigma,
USA) and 5× 106 cells (per well of a 24-well plate) or 5× 107 cells
(per 25 cm2 tissue culture flask) were seeded. Monocytes were then
allowed to adhere for a minimum of 1 h at 37°C. Wells/flasks were
subsequently washed three times in PBS to remove non-adherent
cells. Adherent monocytes were differentiated into MDMs by incu-
bation for 6–7 days at 37°C in RPMI+ 10% FCS (RF10). MDMs
were subsequently washed and infected with IAV (MOI of 0.01)
or mock (RPMI-1640) for 1 h at 37°C. Virus was then removed
and cells were incubated for 16 h in RF10. MDMs were sub-
sequently washed and stained with the relevant antibody (see
Table 1), fixed and analyzed on a FACS Canto flow cytome-
ter (BD Biosciences) with FACSDiva software (BD Biosciences).
Collected samples were analyzed with FLOWJO, version 8.8.7
(TreeStar Inc.).
CYTOKINE PRODUCTION
Levels of cytokines produced by MDMs were measured using the
relevant human ELISA Kits (Sanquin, The Netherlands) at 16-h
post-IAV or mock infection. IFNα production was measured using
a human IFNα ELISA Ready-SET-Go! kit (eBioscience, San Diego,
CA, USA).
Mac-CD8 POLYFUNCTIONALITY ASSAY
The methodology used to assess antigen presentation by human
MDMs is shown in Figure 1. In these experiments, the Epstein–
Barr virus (EBV) derived, HLA-A2 restricted, peptide EBV-
BMLF1280–288(GLCTLVAML) (GLC) (11) was used. GLC was
selected in place of an IAV peptide so that antigen presentation
was independent of the IAV peptides processed and presented as
Table 1 | Antibodies used in the study.
Company Fluorophore Clone
CD14 BD Pharmingen V500 MSE2
HLA-DR BD Pharmingen PE-Cy7 G46-6
IL18R R&D PE 132029
CD163 R&D APC 215927
CD107a eBioscience FITC eBioH4A3
CD3 eBioscience PE-Cy7 UCHT1
CD8 BD Pharmingen PerCP-Cy5.5 S1
IFN-γ BD Pharmingen PE 25723.11
TNF-α BD Pharmingen APC 6401.1111



























FIGURE 1 | An outline for the novel assay measuring interactions
between human MDMs and CD8+ T cells. PBMCs were isolated from the
buffy coats of healthy donors and were screened for HLA-A2 expression.
Monocytes were isolated by plastic adherence, whereas peripheral blood
lymphocytes were used for T cell assays. Monocytes were then
differentiated into macrophages, infected influenza virus (or mock-infected),
and pulsed with peptide. Peripheral blood lymphocytes amplified in vitro
following incubation with peptide-pulsed C1R-A2 cells. Peptide-pulsed
MDMs were co-incubated with peptide-specific T cells and CD8+ T cell
polyfunctionality was assessed by flow cytometry.
a result of infection. In subsequent experiments, we also validated
our new methodology using the IAV-derived, HLA-A2 restricted,
peptide GIL M158–66 GILGFVFTL.
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Generation of peptide-specific CD8+ T cell lines
Firstly, HLA-A2+ human PBMCs were identified by staining of
PBMCs with the HLA-A2+ BB7.2 mAb (a kind donation from the
McCluskey Laboratory, University of Melbourne) and subsequent
FACS analysis. To in vitro amplify CD8+ T cells specific to GLC or
GIL, 1× 107 HLA-A2+ PBMCs were thawed in RF10 and washed
twice in RPMI-1640. Approximately 3.3× 106 PBMCs were then
incubated for 1 h with 10µM GLC or GIL at 37°C. PBMCs were
then washed twice in RPMI-1640 and added to the remaining
PBMCs. Cells were subsequently incubated at 37°C and were sup-
plemented with IL-2 twice weekly from day 3 (20 U/mL, Cetus,
USA). Seven days later C1R cells that were transfected with HLA-
A2 (C1R-A2) were washed twice in RPMI-1640 and incubated
for 1 h with GLC or GIL (10µM) at 37°C. C1R-A2 cells were then
resuspended in RF10 and gamma irradiated at 8000 rad. Following
irradiation, C1R-A2 cells were washed and added to T cell cultures
at a ratio of 1:10 (C1R-A2 cells:T cells) in order to increase the
number of EBV-specific T cells.
Assessment of peptide presentation by MDMs
Seven days later the ability of infected/stimulated MDMs (grown
in a 24-well plate) to present GLC or GIL to autologous, EBV-
specific CD8+ T cells was assessed by flow cytometry. MDMs were
washed once with RPMI-1640 and incubated for 1 h with GLC
or GIL (10µM) at 37°C. Alternatively, MDMs were pulsed with
10µM NS31073–1081CINGVCWTV (CING), a HLA-A2 restricted
peptide derived from Hepatitis C virus (HCV) (12) or 10µL
DMSO. MDMs were then washed and co-incubated with 6× 105
in vitro amplified EBV-specific T cells (per well) for 6 h at 37°C in
the presence of anti-CD107a (Table 1), monensin (5µM; Sigma)
and BD GolgiPlug (BD Biosciences, USA) (13). T cells were subse-
quently removed, washed, and stained for CD3 and CD8 (Table 1).
T cells were then washed, fixed, and permeabilized using the
Cytofix/Cytoperm Fixation/Permeabilization kit (BD Biosciences)
and stained with anti-IFN-γ and anti-TNF-α (Table 1). Cells
were then analyzed on a FACSCantoII or Fortessa with FACS-
Diva software (BD Biosciences). Collected samples were analyzed
with FLOWJO, version 8.8.7 (TreeStar Inc., USA).
RESULTS AND DISCUSSION
To gain insight into interactions between components of innate
and adaptive immunity, and specifically how virus-infected
macrophages impact the functionality of CD8+ T cell responses,
novel assays examining the ability of macrophages to present
antigen to CD8+ T cells are needed. In the present study, we devel-
oped a robust in vitro assay to assess how antigen presentation by
human MDMs affects the functional capacity of autologous CD8+
T cells. The assay is based on polyfunctional characteristics of
antigen-specific CD8+ T cells, and is thus called a Mac-CD8 Poly-
functionality Assay. Polyfunctionality of CD8+ T cells is defined
by simultaneous production of multiple anti-viral cytokines (e.g.,
IFN-γ, TNF-α, and IL-2) (14), and the killing efficacy (assessed
by CD107a; a measure of degranulation) of CD8+ T cells (15).
Such polyfunctional CD8+ T cells producing an array of anti-viral
cytokines are important for effective virus clearance (16, 17).
In our study, we have used the polyfunctional characteristics
of CD8+ T cells to assess the effect of IAV on the CD8-Mac
interaction and the resulting CD8+ T cell responses (Figure 1).
We isolated human peripheral blood monocytes from buffy packs,
matured them to MDMs, infected with IAV or mock, stimulated
with an antigenic peptide and assessed their antigen presenta-
tion to the responding CD8+ T cells by staining with mAbs
to IFN-γ, TNF-α, and CD107a in a multi-color intracellular
cytokine staining (ICS) assay (Figure 1). We have optimized both
the antigen presentation by MDMs as well as culture condi-
tions to ensure maximum expansion of antigen-specific CD8+
T cells. Subsequently, we utilized this novel Mac-CD8 Poly-
functionality Assay to understand the effects of IAV infection
of human macrophages (Figure 2) on antigen presentation to
CD8+ T cells. In these experiments, the EBV-derived peptide
EBV-BMLF1280–288(GLCTLVAML) (GLC) was used for antigen
presentation and T cell expansion to capture antigen presentation
unrelated to influenza virus infection (Figure 3).
OPTIMIZATION OF MACROPHAGE INFECTION AND T CELL
AMPLIFICATION
Macrophages represent a heterogenous population that can be
broadly classified into pro-inflammatory “M1” macrophages and
alternatively activated “M2” macrophages (although this defin-
ition typically represents a spectrum rather than two distinct
groups) (18, 19). Thus, prior to assessing macrophage-CD8+ T
cell interactions, we firstly characterized the M1 and M2 MDM
populations induced by our in vitro culture conditions. It was
evident that our methodology elicits predominately (at >50%)
M1 macrophages (defined as IL18R+CD163− cells) and a smaller
set of M2 macrophages (<20%; defined as IL18R-CD163+)
(Figure 2A) (19).
To assess the ability of virus-infected MDMs to present anti-
gen to CD8+ T cells, we established an IAV infection model.
We used an MOI of 0.01, which resulted in an average infec-
tion rate of approximately 15–20% (Figure 2B), as determined
by GFP-positivity. This was associated with a significant decrease
in CD14 expression but no alteration in MHCII and MHCI
expression (Figure 2C). This decrease in CD14 expression is
consistent with previous studies showing that PR8 decreases
the expression of CD14 on human monocytes (20). Interest-
ingly, influenza infection of MDMs resulted in a 100-fold and
10-fold increase in the production of TNF-α and IL-6, respec-
tively, whilst no dramatic increase was observed in IL-10 produc-
tion (Figure 2D). IFNα production was also increased approxi-
mately 100-fold following IAV infection. Thus, as a MOI of 0.01
altered macrophage function, we continued with this influenza
virus infection regime to investigate macrophage-CD8 T cell
interactions.
In order to increase the sensitivity of the assay and optimize
the in vitro expansion of antigen-specific T cells, we introduced
modifications to our standard in vitro culture and CD8+ T cell-
mediated IFN-γ ICS assay (21). This was essential to assess CD8+
T cell polyfunctionality, as typically, only a subset of CD107a-
positive CD8+ T cells produces cytokines (22). As shown in
Figure 2E, the addition of a second round of in vitro amplifi-
cation (in the presence of GLC-pulsed irradiated, C1R-A2 cells)
resulted in an approximate fourfold increase in the number of
IFN-γ+ CD8+ T cells detected following the presentation of
www.frontiersin.org November 2013 | Volume 4 | Article 389 | 3


































































































FIGURE 2 | Optimization of the Mac-CD8+ polyfunctionality assay.
(A) A representative FACS plot showing IL18R and CD163 expression of
MDMs following incubation of adherent monocytes for 6–7 days at 37°C in
RF10. Percentages represent the proportion of single-cells positive for the
relevant antigen. (B) A representative FACS plot showing the rate of IAV
infection 16-h post-infection at an MOI of 0.01. (C) Mean Fluorescent intensity
(MFI) of CD14, HLA-DR, and HLA-A2 on single-cell MDMs 16 h post-IAV or
mock infection. MFI values for unstained cells (US) are also shown. Data is
pooled from a minimum of three independent donors. Statistical significance
was assessed by a One-Way ANOVA with a Bonferroni post-correction and is
denoted by one asterisk (p<0.05) or two asterisks (p<0.01). (D) Cytokine
production 16 h post-IAV or mock infection of MDMs. Data are expressed as
the fold increase in cytokines produced by IAV-infected MDMs relative to
mock-infected MDMs. Data are pooled from three independent donors and
are shown as the mean±SEM. (E) Fold increase in the percentage of TNF-α+
or IFN-γ+ cells amongst CD3+ CD8+ cells following co-incubation with
GLC-pulsed PBMCs, followed 1 week later by co-incubation with irradiated
C1R-A2 cells pulsed with GLC (2× rounds of amplification). Data is expressed
relative to the percentage of TNF-α+ or IFN-γ+ cells amongst CD3+ CD8+ cells
following in vitro amplification by co-incubation with GLC-pulsed PBMCs (1×
round of amplification). Data are pooled from two independent donors and are
shown as the mean±SEM.
GLC by MDMs. Similarly, the addition of a second round of
in vitro amplification resulted in a sixfold increase in the num-
ber of TNF-α+ CD8+ T cells detected following presentation of
GLC by MDMs (Figure 2E). As a result, T cells were cultured
in vitro for 2 weeks prior to assessing macrophage-CD8+ T cell
interactions.
ANTIGEN PRESENTATION TO CD8+ T CELLS BY HUMANMDMs
Having optimized the conditions to assess antigen presentation
by MDMs, we used the Mac-CD8 Polyfunctionality assay to
determine how infection of MDMs with IAV affected antigen
presentation. Specifically, we compared CD107a, IFN-γ, and TNF-
α expression by CD8+ T cells following their incubation with
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FIGURE 3 | Influenza A virus infection of human MDMs increases
degranulation by EBV (GLC) specific CD8+ T cells. (A) CD107a,
(B) IFN-γ, or (C) TNF-α expression by single-cell, CD3+ CD8+ T cells
following 6 h co-incubation with IAV- or mock-infected GLC-pulsed
MDMs. Alternatively, T cells were incubated with MDMs pulsed with
an irrelevant peptide (IP) derived from HCV (“control”). Data are pooled
from four independent donors and statistical significance was
assessed by a One-Way ANOVA with a Bonferroni post-correction and
is denoted by one asterisk (p<0.05), two asterisk (p<0.01), or three
asterisks (p<0.001). (D) Polyfunctionality of CD8+ T cells following 6 h
stimulation with peptide-pulsed MDMs. CD3+ CD8+ T cells
expressing/producing combinations of CD107a, IFN-γ, and TNF-α from
four independent donors are averaged and represented as a proportion
of CD3+ CD8+ T cells.
IAV- or mock-infected MDMs presenting the GLC peptide.
Our novel assay was sufficiently sensitive to detect significant
increases in CD8+ T cell degranulation (CD107a expression) by
IAV-infected MDMs relative to mock-infected MDMs (p< 0.01;
Figure 3A). There was also a trend toward increased IFN-γ and
TNF-α expression upon IAV infection, although these differences
were not significant (p> 0.05; Figures 3B,C). There was lim-
ited CD8+ T cell degranulation or cytokine production observed
following incubation of MDMs with an irrelevant HLA-A2+
restricted HCV peptide (CING), confirming the specificity of the
Mac-CD8 Polyfunctionality assay (Figures 3A–C).
Importantly, this methodology provides data on the qualita-
tive (in addition to quantitative) aspects of CD8+ T cells, termed
polyfunctionality. Pooled results from four donors show that there
was no difference in polyfunctionality observed between mock-
and IAV-infected MDMs (Figure 3D). We observed preferential
induction of CD8+ T cells with exclusive cytotoxic capacity (rather
than cytokine-producers) by IAV-infected peptide-pulsed MDMs
(Figure 3D). This hints that the main task of CD8+ T cells during
influenza virus infection is to kill virally infected cells at the site
of infection rather than produce anti-viral cytokines. To confirm
that these findings were not restricted to the presentation of an
EBV-derived peptide, we also performed the Mac-CD8 Polyfunc-
tionality assay using an IAV-derived antigen (M1). Consistent with
our previous data, we also saw a trend toward increased CD107a
expression by CD8+ T cells following co-incubation with IAV-
infected macrophages (relative to mock-infected macrophages)
(Figure 4). Furthermore, we confirmed our findings of a preferen-
tial induction of CD8+ T cells with exclusive cytotoxic capacity by
human MDMs following IAV infection (Figure 4). Interestingly,
presentation of the M1 antigen by mock-infected MDMs resulted
in a large number of T cells which produced IFN-γ in the absence
of CD107a expression (Figure 4).
Taken together, we have demonstrated a novel in vitro assay
to assess antigen presentation by human MDMs to autologous
CD8+ T cells. This method shows that infection with IAV results
in increased the presentation of both a model antigen and an IAV-
derived antigen to CD8+ T cells. This assay could be adapted to
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FIGURE 4 | Influenza A virus infection of human MDMs increases
degranulation by influenza (GIL)-specific CD8+ T cells. (A) CD107a,
(B) IFN-γ, or (C) TNF-α expression by single-cell, CD3+ CD8+ T cells following
6 h co-incubation with IAV- or mock-infected M1-pulsed MDMs. The
percentage of positive cells detected following co-incubation with
mock-infected macrophages pulsed with 10µL DMSO (instead of peptide)
was subtracted from the relevant values. Data are pooled from three
independent donors and each donor is indicated with a different color.
(D) Polyfunctionality of CD8+ T cells following 6 h stimulation with
peptide-pulsed MDMs. CD3+ CD8+ T cells expressing/producing
combinations of CD107a, IFN-γ, and TNF-α from three independent donors are
averaged and represented as a proportion of total CD3+ CD8+ T cells.
assess how a variety of other viral infections may alter antigen
presentation by human MDMs. It would also be possible to fur-
ther modify this methodology to assess antigen presentation by
human alveolar macrophages, in order to most accurately depict
the cell-to-cell interactions that occur in the lung. Thus, in sum-
mary, the present manuscript provides a novel methodology that
can be used to provide new insights to our understanding of the
complex interactions that occur between the innate and adaptive
immune response.
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